COAGULATION DEFECT IN HEMOPHILIA A CAUSED BY AN INHIBITOR

被引：0
|
作者：
MAMMEN, E
机构：
来源：
THROMBOSIS ET DIATHESIS HAEMORRHAGICA | 1963年 / 9卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：228 / &
相关论文
共 50 条
  • [41] ABNORMAL BLOOD COAGULATION IN CARRIERS OF HEMOPHILIA
    MILLER, SP
    SIGGERUD, J
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1964, 63 (04): : 621 - +
  • [42] A NEW COAGULATION DEFECT
    TELFER, TP
    DENSON, KW
    WRIGHT, DR
    BRITISH JOURNAL OF HAEMATOLOGY, 1956, 2 (03) : 308 - 316
  • [43] COAGULATION DEFECT AND HEPARIN
    COOPLAND, AT
    OBSTETRICS AND GYNECOLOGY, 1970, 36 (06): : 957 - &
  • [44] SEVERE BLEEDING CAUSED BY AN INHIBITOR TO COAGULATION-FACTOR-V - A CASE-REPORT
    SMID, WM
    DEWOLF, JTM
    NIJLAND, JH
    BOM, VJJ
    VANDERMEER, J
    BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (01) : 133 - 137
  • [45] Perioperative Monitoring with Global Coagulation Test in Severe Hemophilia a without Inhibitor on Emicizumab Prophylaxis Undergoing Orthopedic Surgery
    Dos Santos Ortas, Abel
    Martin De Bustamante Gonzalez-Iglesias, Jose Manuel
    Perez Vaquero, Maria Isabel
    Alvarez Roman, Maria Teresa
    Rivas Pollmar, Maria Isabel
    Martin Salces, Monica
    Garcia Perez, Eduardo
    Gutierrez, Mar
    Arias-Salgado, Elena G.
    Butta, Nora, V
    Acuna, Paula
    Monzon Manzano, Elena
    Hermans, Cedric
    Jimenez-Yuste, Victor
    BLOOD, 2022, 140 : 11302 - 11303
  • [46] An Aptamer Antagonist of Tissue Factor Pathway Inhibitor Improves Coagulation in Hemophilia A and FVIII Antibody-Treated Plasma
    Waters, Emily K.
    Kurz, Jeffrey C.
    Genga, Ryan
    Nelson, Jennifer A.
    McGinness, Kathleen E.
    Schaub, Robert G.
    BLOOD, 2009, 114 (22) : 228 - 228
  • [47] TREATMENT TACTICS FOR A PATIENT WITH ACQUIRED HEMOPHILIA: CONTINUOUS INFUSION OF RECOMBINANT ACTIVATED COAGULATION FACTOR VII AND THE INHIBITOR ERADICATION
    Galstyan, G. M.
    Nalbandyan, S. A.
    Sabirov, K. R.
    Soboleva, O. A.
    Kovalenko, A., V
    Gorgidze, L. A.
    Zorenko, V. Y.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (02): : 282 - 294
  • [48] Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice
    Verma, Dheeraj
    Moghimi, Babak
    LoDuca, Paul A.
    Singh, Harminder D.
    Hoffman, Brad E.
    Herzog, Roland W.
    Daniell, Henry
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (15) : 7101 - 7106
  • [49] HEMOPHILIA-B+ WITH INHIBITOR
    LUDWIG, M
    SCHWAAB, R
    OLEK, K
    BRACKMANN, HH
    EGLI, H
    THROMBOSIS AND HAEMOSTASIS, 1988, 59 (02) : 340 - 340
  • [50] Immunobiology of inhibitor development in hemophilia A
    Fijnvandraat, K
    Bril, WS
    Voorberg, J
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2003, 29 (01): : 61 - 68
12345